Insulin glargine and lixisenatide Subcutaneous and Lenvima 10 MG Daily Dose
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Lenvima 10 MG Daily Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvima
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Lenvima 12 MG Daily Dose
- Insulin glargine and lixisenatide Subcutaneous-Lenvima 4 MG Daily Dose
- Insulin glargine and lixisenatide Subcutaneous-LenzaGel
- Insulin glargine and lixisenatide Subcutaneous-LenzaPatch
- Insulin glargine and lixisenatide Subcutaneous-Lescol
- Insulin glargine and lixisenatide Subcutaneous-Lescol XL
- Lenvima 10 MG Daily Dose-Insulin glargine, recombinant Subcutaneous
- Lenvima 10 MG Daily Dose-Insulin glulisine
- Lenvima 10 MG Daily Dose-Insulin Glulisine (Cartridges and Pens)
- Lenvima 10 MG Daily Dose-Insulin Glulisine (Vials)
- Lenvima 10 MG Daily Dose-Insulin glulisine Subcutaneous
- Lenvima 10 MG Daily Dose-Insulin human inhaled Inhalation